News & media

Blog

8 August 2018

New White Paper – Innovations in Cancer Screening

New White Paper – Innovations in Cancer Screening There has been great progress in the diagnosis and treatment of cancer in recent years, driven largely by the increased use of medical imaging technologies. As the world’s population ages, the number of new cases of cancer is set to rise — to 21.7 million new cases by 2030[i] —  which necessitates improved efficiencies in the use of imaging technologies. A new White Paper, Innovations in Read more

10 July 2018

Demystifying How Images Are Managed

Demystifying How Images Are Managed Between February 2017 and January 2018, ~41.4 million diagnostic imaging tests were performed in England[i]. That so many imaging tests were performed in a country with a population of ~55.3 million[ii] provides a small snapshot of the sheer volume of imaging data generated globally. As medical imaging has advanced in the digital age, so has managing and sharing the generated data. In this post, we provide a brief overview Read more

18 June 2018

ASCO 2018: Headlines and Highlights

ASCO 2018: Headlines and Highlights All eyes were on the American Society of Clinical Oncology (ASCO) Annual conference last week in Chicago watching for the latest clinical trial updates and translational innovations that will be tomorrow’s breakthrough cancer treatments and tests. Each year, the event attracts thousands working in the cancer field. And each year, the research presented at ASCO sets the tone for the cancer community in terms of what’s hot, and what’s Read more

15 May 2018

Immunotherapy Update: Recent Advances in CAR T-cell Therapy

Immunotherapy Update: Recent Advances in CAR T-cell Therapy As a measure of its promise, chimeric antigen receptor (CAR) T-cell therapy – where patients’ own immune cells are collected, genetically changed and used to treat their cancer – is the American Society of Clinical Oncology (ASCO) Advance of the Year for 2018.[i] This approach represents an exciting innovation that has the potential to transform cancer care.[ii] CAR T-cell therapy is clinically the most advanced of Read more